1. Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. 2. Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. 3. Department of Orthopedics, First Affiliated Hospital of Shantou University Medical College, No.57 Changping Road, Shantou, Guangdong 515041, China. 4. Department of Orthopedics, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. #These authors contributed equally to this work.
✉ Corresponding authors: Jing-Ping Yun or Suxia Lin, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. E-mail address: yunjporg.cn, or linsxorg.cn.More
Citation:
Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, Wang J, Lin S, Yun JP. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum. Theranostics 2022; 12(10):4604-4605. doi:10.7150/thno.74233. https://www.thno.org/v12p4604.htm
Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, Wang J, Lin S, Yun JP. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum. Theranostics 2022; 12(10):4604-4605. doi:10.7150/thno.74233. https://www.thno.org/v12p4604.htm
CSE
Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, Wang J, Lin S, Yun JP. 2022. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts: Erratum. Theranostics. 12(10):4604-4605.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.